Clinical Trials

Phase 3 Active not recruiting

Ovarian Neoplasms

NCT06353906 2025-12-08

PRIAM

Phase 2 Recruiting

27 enrolled

Genitourinary

Penile Neoplasms, Urogenital Neoplasms, Urologic Neoplasms, Male Urogenital Diseases

NCT05201547 2025-12-04

DOMENICA

260 enrolled

Phase 2 Not yet recruiting

Neoplasm Metastasis, Endometrial Neoplasms

NCT04460352 2025-03-06

NEEDS

Phase 3 Recruiting

1,020 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06713057 2024-12-03

Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer

20 enrolled

Head & Neck

Thyroid Neoplasms

NCT01404156 2024-08-28

POWERRANGER

Phase 2/3 Completed

29 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms

NCT06102252 2024-08-06

Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma

Phase NA Not yet recruiting

80 enrolled

Endometrial Neoplasms

NCT05992610 2023-08-15

iCHRTL

Phase NA Recruiting

40 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Laryngeal Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

NCT05963334 2023-07-27

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Phase 1/2 Completed

49 enrolled

Classical hematology

Anemia, Neutropenia, Thrombocytopenia

NCT01367002 2023-05-17

Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer

61 enrolled 13 charts

Endometrial Neoplasms

NCT05294900 2022-03-25

NEOS

79 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT02878122 2021-08-17

FaCliBioCCo

Completed

13 enrolled

Ovarian Neoplasms

NCT04982549 2021-08-06

A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC

35 enrolled

Unresectable Stage III NSCLC

NCT04337632 2021-04-08

Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer

Phase 3 Unknown

338 enrolled

Ovarian Neoplasms

NCT01314833 2020-05-19

Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy

1,570 enrolled

Primary Breast Cancer

NCT00226915 2020-02-17

Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma

637 enrolled

Phase EARLY_PHASE1 Unknown

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03940001 2019-09-09

A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer

20 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03562533 2019-02-28

Real-World Effectiveness of PLD in Platinum- Sensitive Recurrent Ovarian Cancer

Completed

432 enrolled

Ovarian Neoplasms

NCT00689156 2018-04-05

READ

2,015 enrolled

Breast Neoplasms

NCT00584857 2017-01-27

A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer

30 enrolled 8 charts

Uterine Neoplasms

NCT00912444 2016-11-22

NATT

Phase 3 Terminated

102 enrolled

Breast Neoplasms

NCT02207361 2015-12-22

Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer

Phase 4 Unknown

120 enrolled

Breast Neoplasms

NCT00538603 2015-12-17

Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)

Phase NA Completed

8 enrolled

Carcinoma, Ovarian Epithelial

NCT00052468 2014-06-25

AGO-OVAR9

1,742 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00298415 2013-10-25

Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)

451 enrolled

NSCLC

NCT01872403 2013-06-07

Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the Lung

120 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01196234 2013-01-29

PRIDE

84 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00340184 2010-10-19

A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer Patients

55 enrolled

Uterine Cervical Neoplasms

NCT01203267 2010-09-16

Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer

108 enrolled

Pathologic Complete Response, Breast Neoplasms

NCT01158144 2010-07-08

Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)

134 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00894569 2009-05-14

PACET-CUP

150 enrolled

Tumor-Agnostic

Carcinoma, Neoplasms, Unknown Primary

NCT00259675 2007-11-15

Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00144053 2006-01-06

A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer

450 enrolled